Different cellular barriers to RNA therapeutics and strategies to overcome-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Different cellular barriers to RNA therapeutics and strategies to overcome

Published:2023-03-02 Issue:1 Volume:110 Page:571-573
ISSN:1743-9159
Container-title:International Journal of Surgery
language:en
Short-container-title:

Author:

Chatterjee Srijan¹,Bhattacharya Manojit²,Agoramoorthy Govindasamy³,Chakraborty Chiranjib¹^ORCID

Affiliation:

1. Department of Biotechnology, School of Life Science and Biotechnology, Adamas University, Kolkata, West Bengal, India

2. Department of Zoology, Fakir Mohan University, Vyasa Vihar, Balasore, Odisha, India

3. College of Pharmacy and Health Care, Tajen University, Yanpu, Pingtung, Taiwan

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine,Surgery

Reference23 articles.

1. Therapeutic advances of miRNAs: a preclinical and clinical update;Chakraborty;J Adv Res,2021

2. Therapeutic miRNA and siRNA: moving from bench to clinic as next generation medicine;Chakraborty;Mol Ther Nucleic Acids,2017

3. Overcoming cellular barriers for RNA therapeutics;Dowdy;Nat Biotechnol,2017

4. RNA therapeutics on the rise;Wang;Nat Rev Drug Discov,2020

5. RNA-based therapeutics: an overview and prospectus;Zhu;Cell Death Dis,2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP